Connecting for innovation and impact for all in global health
On February 25, Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, led a session for Stanford Mussallem Center for Biodesign’s Innovation and Health Equity Series. She discussed how outcomes-based financing (OBF) can be leveraged to tackle antimicrobial resistance (AMR). Her talk, which provided a first look at data from a year-long study in Tanzania and Senegal, emphasized how innovative financing mechanisms could reshape global health strategies.
During the Clinton Global Initiative (CGI) 2024 Annual Meeting, PATH, in partnership with the Bay Area Global Health Alliance and Pfizer, announced a Commitment to Action: Outcomes-Based Financing as a Tool to Curb AMR in LMICs. This commitment aims to combat antimicrobial resistance (AMR) and incentivize antimicrobial stewardship (AMS) through an innovative outcomes-based financing mechanism.
The 79th session of the UN General Assembly (UNGA 79) will open on Tuesday, 10 September 2024. The first day of the high-level General Debate will be Tuesday, 24 September 2024. When global leaders meet at the UN, they will confront yet another year of complex crises and conflicts — as a deeply divided world watches. The UN is the only place on Earth where countries — whether big or small — have a say. The debates and conversations that will unfold during UNGA 79 will shape the solutions that can redefine our future. UNGA 79 will also include High-level Meetings on two issues of existential importance: Antimicrobial resistance (AMR) and the global threat of sea-level rise.
Join Cepheid for their Race Against Resistance: Global Perspectives on Tackling AMR webinar, which will share cross-regional expertise, including real-world lived experience of managing outbreaks, meta-analysis and novel diagnostic approaches in the fight against antimicrobial resistance and threat to last-line antibiotics.